Stem cells may reshape the prospect of Parkinson's disease therapy

Molecular Brain Research

Volumn 134, Issue 1, 2005, Pages 34-51

  Sonntag, Kai Christian ^a   Simantov, Rabi ^a,b   Isacson, Ole ^a  

^a MCLEAN HOSPITAL   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cell replacement; Dopaminergic; Embryonic stem (ES) cells; ES cell differentiation; Neurogenesis; Parkinson's disease; Transplantation

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ACCURACY; CARCINOGENESIS; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL LOSS; CELL MATURATION; CELL SPECIFICITY; CELL SURVIVAL; CELL TRANSPLANTATION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; FETUS (ANATOMY); GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; MONOCULTURE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PARKINSON DISEASE; PATIENT; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SPECIES DIFFERENCE; STEM CELL; TOTIPOTENT STEM CELL; TRANSGENE;

EID: 15544369505     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.09.002     Document Type: Review

References (164)

1. L.D. Adams, L. Choi, H.Q. Xian, A. Yang, B. Sauer, L. Wei, and D.I. Gottlieb Double lox targeting for neural cell transgenesis Brain Res. Mol. Brain Res. 110 2003 220 233
2. E. Arenas Stem cells in the treatment of Parkinson's disease Brain Res. Bull. 57 2002 795 808
3. L. Attisano, and J.L. Wrana Smads as transcriptional co-modulators Curr. Opin. Cell Biol. 12 2000 235 243
4. H. Auchincloss Jr., and D.H. Sachs Xenogeneic transplantation Annu. Rev. Immunol. 16 1998 433 470
5. R. Awatramani, P. Soriano, J.J. Mai, and S. Dymecki An Flp indicator mouse expressing alkaline phosphatase from the ROSA26 locus Nat. Genet. 29 2001 257 259
6. T. Barberi, P. Klivenyi, N.Y. Calingasan, H. Lee, H. Kawamata, K. Loonam, A.L. Perrier, J. Bruses, M.E. Rubio, N. Topf, V. Tabar, N.L. Harrison, M.F. Beal, M.A. Moore, and L. Studer Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice Nat. Biotechnol. 21 2003 1200 1207
7. R. Barker, and S. Dunnett The biology and behaviour of intracerebral adrenal transplants in animals and man Rev. Neurosci. 4 1993 113 146
8. R.A. Barker, E. Ratcliffe, M. McLaughlin, A. Richards, and S.B. Dunnett A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease J. Neurosci. 20 2000 3415 3424
9. M.S. Baron, J.L. Vitek, R.A. Bakay, J. Green, Y. Kaneoke, T. Hashimoto, R.S. Turner, J.L. Woodard, S.A. Cole, W.M. McDonald, and M.R. DeLong Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study Ann. Neurol. 40 1996 355 366
10. J.C. Bensadoun, N. Deglon, J.L. Tseng, J.L. Ridet, A.D. Zurn, and P. Aebischer Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF Exp. Neurol. 164 2000 15 24
11. C. Bianco, H.B. Adkins, C. Wechselberger, M. Seno, N. Normanno, A. De Luca, Y. Sun, N. Khan, N. Kenney, A. Ebert, K.P. Williams, M. Sanicola, and D.S. Salomon Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial cells Mol. Cell. Biol. 22 2002 2586 2597
12. A. Bjorklund, S. Dunnett, U. Stenevi, M. Lewis, and S. Iversen Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing Brain Res. 199 1980 307 333
13. L.M. Bjorklund, R. Sánchez-Pernaute, S. Chung, T. Andersson, I. Chen, I.Y. Chen, K. McNaught, A.-L. Brownell, B.G. Jenkins, C. Wahlestedt, K.-S. Kim, and O. Isacson Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model Proc. Natl. Acad. Sci. U. S. A. 99 2002 2344 2349
14. A. Bjorklund, S.B. Dunnett, P. Brundin, A.J. Stoessl, C.R. Freed, R.E. Breeze, M. Levivier, M. Peschanski, L. Studer, and R. Barker Neural transplantation for the treatment of Parkinson's disease Lancet Neurol. 2 2003 437 445
15. V. Bonifati, P. Rizzu, M.J. van Baren, O. Schaap, G.J. Breedveld, E. Krieger, M.C. Dekker, F. Squitieri, P. Ibanez, M. Joosse, J.W. van Dongen, N. Vanacore, J.C. van Swieten, A. Brice, G. Meco, C.M. van Duijn, B.A. Oostra, and P. Heutink Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 299 2003 256 259
16. C.V. Borlongan, C.E. Stahl, D.F. Cameron, S. Saporta, T.B. Freeman, D.W. Cahill, and P.R. Sanberg CNS immunological modulation of neural graft rejection and survival Neurol. Res. 18 1996 297 304
17. H. Braak, K. Del Tredici, U. Rub, R.A. de Vos, E.N. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol. Aging 24 2003 197 211
18. M. Carlen, R.M. Cassidy, H. Brismar, G.A. Smith, L.W. Enquist, and J. Frisen Functional integration of adult-born neurons Curr. Biol. 12 2002 606 608
19. M.K. Carpenter, M.S. Inokuma, J. Denham, T. Mujtaba, C.P. Chiu, and M.S. Rao Enrichment of neurons and neural precursors from human embryonic stem cells Exp. Neurol. 172 2001 383 397
20. R.F. Castilho, O. Hansson, and P. Brundin Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease Prog. Brain Res. 127 2000 203 231
21. P. Cazorla, M.P. Smidt, K.L. O'Malley, and J.P. Burbach A response element for the homeodomain transcription factor Ptx3 in the tyrosine hydroxylase gene promoter J. Neurochem. 74 2000 1829 1837 (in process citation)
22. N. Chi, and J.A. Epstein Getting your Pax straight: Pax proteins in development and disease Trends Genet. 18 2002 41 47
23. N. Christ, and P. Droge Genetic manipulation of mouse embryonic stem cells by mutant lambda integrase Genesis 32 2002 203 208
24. S. Chung, T. Andersson, K.C. Sonntag, L. Bjorklund, O. Isacson, and K.S. Kim Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines Stem Cells 20 2002 139 145
25. S. Chung, K.C. Sonntag, T. Andersson, L.M. Bjorklund, J.J. Park, D.W. Kim, U.J. Kang, O. Isacson, and K.S. Kim Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons Eur. J. Neurosci. 16 2002 1829 1838
26. F. Cicchetti, W. Fodor, T.W. Deacon, C. Van Horne, S. Rollins, W. Burton, L.C. Costantini, and O. Isacson Immune parameters relevant to neural xenograft survival in the primate brain Xenotranspl. 10 2003 41 49
27. V. Coskun, and M.B. Luskin Intrinsic and extrinsic regulation of the proliferation and differentiation of cells in the rodent rostral migratory stream J. Neurosci. Res. 69 2002 795 802
28. L.C. Costantini, D. Cole, P. Chaturvedi, and O. Isacson Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease Eur. J. Neurosci. 13 2001 1085 1092
29. T. Deacon, J. Dinsmore, L. Costantini, J. Ratliff, and O. Isacson Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation Exp. Neurol. 149 1998 28 41
30. T.W. Deacon, W. Fodor, S. Rollins, S. Squinto, L.C. Costantini, L. Matis, L. Bell, and O. Isacson Xenotransplantation of transgenic fetal pig dopamine neurons to rats and systemic prevention of host complement-mediated cell lysis Soc. Neurosci. 24 1998 1056 (Abstract 421.9)
31. R.M. de Bie, R.J. de Haan, P.R. Schuurman, R.A. Esselink, D.A. Bosch, and J.D. Speelman Morbidity and mortality following pallidotomy in Parkinson's disease: a systematic review Neurology 58 2002 1008 1012
32. R.B. Dewey Jr. Management of motor complications in Parkinson's disease Neurology 62 2004 S3 S7
33. J. Ding, L. Yang, Y.T. Yan, A. Chen, N. Desai, A. Wynshaw-Boris, and M.M. Shen Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo Nature 395 1998 702 707
34. W.M. Duan, C.M. Rodrigues, L.R. Zhao, C.J. Steer, W.C. Low, and C.M. Rodrigures Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease Cell Transplant 11 2002 195 205
35. S.B. Dunnett, S.T. Bunch, F.H. Gage, and A. Bjorklund Dopamine-rich transplants in rats with 6-OHDA lesions of the ventral tegmental area: 1. Effects on spontaneous and drug-induced locomotor activity Behav. Brain Res. 13 1984 71 82
36. G. Dziewczapolski, D.C. Lie, J. Ray, F.H. Gage, and C.W. Shults Survival and differentiation of adult rat-derived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats Exp. Neurol. 183 2003 653 664
37. M. Emgard, U. Hallin, J. Karlsson, B.A. Bahr, P. Brundin, and K. Blomgren Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation J. Neurochem. 86 2003 1223 1232
38. T.A. Ferguson, D.R. Green, and T.S. Griffith Cell death and immune privilege Int. Rev. Immunol. 21 2002 153 172
39. J.S. Fink, J.M. Schumacher, S.L. Ellias, E.P. Palmer, M. Saint-Hilaire, K. Shannon, R. Penn, P. Starr, C. VanHorne, H.S. Kott, P.K. Dempsey, A.J. Fischman, R. Raineri, C. Manhart, J. Dinsmore, and O. Isacson Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results Cell Transplant 9 2000 273 278
40. H. Frielingsdorf, K. Schwarz, P. Brundin, and P. Mohapel No evidence for new dopaminergic neurons in the adult mammalian substantia nigra Proc. Natl. Acad. Sci. U. S. A. 101 2004 10177 10182
41. D.C. German, M. Dubach, S. Askari, S.G. Speciale, and D.M. Bowden 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? Neuroscience 24 1988 161 174
42. S.S. Gill, N.K. Patel, G.R. Hotton, K. O'Sullivan, R. McCarter, M. Bunnage, D.J. Brooks, C.N. Svendsen, and P. Heywood Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat. Med. 9 2003 589 595
43. I. Ginis, Y. Luo, T. Miura, S. Thies, R. Brandenberger, S. Gerecht-Nir, M. Amit, A. Hoke, M.K. Carpenter, J. Itskovitz-Eldor, and M.S. Rao Differences between human and mouse embryonic stem cells Dev. Biol. 269 2004 360 380
44. M. Gossen, and H. Bujard Tight control of gene expression in mammalian cells by tetracycline-responsive promoters Proc. Natl. Acad. Sci. U. S. A. 89 1992 5547 5551
45. M. Gossen, A.L. Bonin, and H. Bujard Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements Trends Biochem. Sci. 18 1993 471 475
46. M. Gossen, S. Freundlieb, G. Bender, G. Muller, W. Hillen, and H. Bujard Transcriptional activation by tetracyclines in mammalian cells Science 268 1995 1766 1769
47. A.M. Graybiel Neural networks: neural systems: V: basal ganglia Am. J. Psychiatry 158 2001 21
48. A.K. Halladay, Y. Yue, L. Michna, D.A. Widmer, G.C. Wagner, and R. Zhou Regulation of EphB1 expression by dopamine signaling Brain Res. Mol. Brain Res. 85 2000 171 178
49. C.E. Helt, G.R. Hoernig, D.S. Albeck, G.A. Gerhardt, B. Ickes, M.E. Reyland, D.O. Quissell, I. Stromberg, and A.C. Granholm Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail Exp. Neurol. 170 2001 258 269
50. J.P. Himanen, and D.B. Nikolov Eph receptors and ephrins Int. J. Biochem. Cell Biol. 35 2003 130 134
51. K.H. Holm, F. Cicchetti, L. Bjorklund, Z. Boonman, P. Tandon, L.C. Costantini, T.W. Deacon, X. Huang, D.F. Chen, and O. Isacson Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum Neuroscience 104 2001 397 405
52. A.B. Huber, A.L. Kolodkin, D.D. Ginty, and J.F. Cloutier Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance Annu. Rev. Neurosci. 26 2003 509 563
53. C.B. Hurelbrink, R.J. Armstrong, L.M. Luheshi, S.B. Dunnett, A.E. Rosser, and R.A. Barker Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation Exp. Neurol. 171 2001 46 58
54. M. Hynes, and A. Rosenthal Specification of dopaminergic and serotonergic neurons in the vertebrate CNS Curr. Opin. Neurobiol. 9 1999 26 36
55. O. Isacson The production and use of cells as therapeutic agents in neurodegenerative diseases Lancet Neurol. 2 2003 417 424
56. O. Isacson Problems and solutions for circuits and synapses in Parkinson's disease Neuron 43 2004 165 168
57. O. Isacson, and T.W. Deacon Neural transplantation studies reveal the brain's capacity for continuous reconstruction. Trends Neurosci. 20 1997 477 482
58. O. Isacson, T.W. Deacon, P. Pakzaban, W.R. Galpern, J. Dinsmore, and L.H. Burns Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres Nat. Med. 1 1995 1189 1194
59. O. Isacson, L.M. Bjorklund, and J.M. Schumacher Towards full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease from regeneration and neuronal replacement by stem cells Ann. Neurol. 53 2003 135 148
60. F. Javoy-Agid, and Y. Agid Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology 30 1980 1326 1330
61. H. Kawasaki, K. Mizuseki, S. Nishikawa, S. Kaneko, Y. Kuwana, S. Nakanishi, S.-I. Nishikawa, and Y. Sasai Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity Neuron 28 2000 31 40
62. H. Kawasaki, H. Suemori, K. Mizuseki, K. Watanabe, F. Urano, H. Ichinose, M. Haruta, M. Takahashi, K. Yoshikawa, S. Nishikawa, N. Nakatsuji, and Y. Sasai Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity Proc. Natl. Acad. Sci. U. S. A. 99 2002 1580 1585
63. G. Keller, C. Wall, A.Z. Fong, T.S. Hawley, and R.G. Hawley Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential Blood 92 1998 877 887
64. D.W. Kim Efficient induction of dopaminergic neurons from embryonic stem cells for application to Parkinson's disease Yonsei Med. J. 45 2004 S23 S27 (Suppl.)
65. J.-H. Kim, J.M. Auerbach, J.A. Rodriguez-Gomez, I. Velasco, D. Gavin, N. Lumelsky, S.-H. Lee, J. Nguyen, R. Sanchez-Pernaute, K. Bankiewicz, and R. McKay Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease Nature 418 2002 50 56
66. J. Kim, L. Lo, E. Dormand, and D.J. Anderson SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells Neuron 38 2003 17 31
67. J.Y. Kim, H.C. Koh, J.Y. Lee, M.Y. Chang, Y.C. Kim, H.Y. Chung, H. Son, Y.S. Lee, L. Studer, R. McKay, and S.H. Lee Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression J. Neurochem. 85 2003 1443 1454
68. K.S. Kim, C.H. Kim, D.Y. Hwang, H. Seo, S. Chung, S.J. Hong, J.K. Lim, T. Anderson, and O. Isacson Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner J. Neurochem. 85 2003 622 634
69. C. Kimura, M.M. Shen, N. Takeda, S. Aizawa, and I. Matsuo Complementary functions of Otx2 and Cripto in initial patterning of mouse epiblast Dev. Biol. 235 2001 12 32
70. D. Kirik, B. Georgievska, and A. Bjorklund Localized striatal delivery of GDNF as a treatment for Parkinson disease Nat. Neurosci. 7 2004 105 110
71. H. Kishima, T. Poyot, J. Bloch, J. Dauguet, F. Conde, F. Dolle, F. Hinnen, W. Pralong, S. Palfi, N. Deglon, P. Aebischer, and P. Hantraye Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons Neurobiol. Dis. 16 2004 428 439
72. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima, M. Yokochi, Y. Mizuno, and N. Shimizu Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608
73. J. Kordower, J. Rosenstein, T. Collier, M. Burke, E. Chen, J. Li, L. Martel, A. Levey, E. Mufson, T. Freeman, and C. Olanow Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370 1996 203 230
74. J.H. Kordower, M.E. Emborg, J. Bloch, S.Y. Ma, Y. Chu, L. Leventhal, J. McBride, E.Y. Chen, S. Palfi, B.Z. Roitberg, W.D. Brown, J.E. Holden, R. Pyzalski, M.D. Taylor, P. Carvey, Z. Ling, D. Trono, P. Hantraye, N. Deglon, and P. Aebischer Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 290 2000 767 773
75. B.R. Ksander, and J.W. Streilein Regulation of the immune response within privileged sites Chem. Immunol. 58 1994 117 145
76. H.C. Kuo, K.Y. Pau, R.R. Yeoman, S.M. Mitalipov, H. Okano, and D.P. Wolf Differentiation of monkey embryonic stem cells into neural lineages Biol. Reprod. 68 2003 1727 1735
77. L.C. Larsson, K.A. Czech, P. Brundin, and H. Widner Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: immune responses and functional effects Cell Transplant 9 2000 261 272
78. S.E. Lazic, and R.A. Barker The future of cell-based transplantation therapies for neurodegenerative disorders J. Hematother. Stem Cell Res. 12 2003 635 642
79. S.H. Lee, N. Lumelsky, L. Studer, J.M. Auerbach, and R.D. McKay Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells Nat. Biotechnol. 18 2000 675 679
80. E. Leroy, R. Boyer, G. Auburger, B. Leube, G. Ulm, E. Mezey, G. Harta, M.J. Brownstein, S. Jonnalagada, T. Chernova, A. Dehejia, C. Lavedan, T. Gasser, P.J. Steinbach, K.D. Wilkinson, and M.H. Polymeropoulos The ubiquitin pathway in Parkinson's disease Nature 395 1998 451 452
81. J. Lim, C. Yang, S.J. Hong, and K.S. Kim Regulation of tyrosine hydroxylase gene transcription by the cAMP-signaling pathway: involvement of multiple transcription factors Mol. Cell. Biochem. 212 2000 51 60
82. J.C. Lin, and A. Rosenthal Molecular mechanisms controlling the development of dopaminergic neurons Semin. Cell Dev. Biol. 14 2003 175 180
83. Z. Lin, P.W. Zhang, X. Zhu, J.M. Melgari, R. Huff, R.L. Spieldoch, and G.R. Uhl Phosphatidylinositol 3-kinase, protein kinase C, and MEK1/2 kinase regulation of dopamine transporters (DAT) require N-terminal DAT phosphoacceptor sites J. Biol. Chem. 278 2003 20162 20170
84. T. Lindsten, J.A. Golden, W.X. Zong, J. Minarcik, M.H. Harris, and C.B. Thompson The proapoptotic activities of Bax and Bak limit the size of the neural stem cell pool J. Neurosci. 23 2003 11112 11119
85. O. Lindvall Stem cells for cell therapy in Parkinson's disease Pharmacol. Res. 47 2003 279 287
86. Y. Ma, A. Ramezani, R. Lewis, R.G. Hawley, and J.A. Thomson High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors Stem Cells 21 2003 111 117
87. S.S. Magavi, B.R. Leavitt, and J.D. Macklis Induction of neurogenesis in the neocortex of adult mice Nature 405 2000 951 955
88. A.A. Mangi, N. Noiseux, D. Kong, H. He, M. Rezvani, J.S. Ingwall, and V.J. Dzau Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts Nat. Med. 9 2003 1195 1201
89. D.M. Marchionini, T.J. Collier, M. Camargo, S. McGuire, M. Pitzer, and C.E. Sortwell Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease J. Comp. Neurol. 464 2003 172 179
90. P.L. McGeer, S. Itagaki, H. Akiyama, and E.G. McGeer Rate of cell death in parkinsonism indicates active neuropathological process Ann. Neurol. 24 1988 574 576
91. I. Mendez, A. Dagher, M. Hong, P. Gaudet, S. Weerasinghe, V. McAlister, D. King, J. Desrosiers, S. Darvesh, T. Acorn, and H. Robertson Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases J. Neurosurg. 96 2002 589 596
92. G. Minchiotti, S. Parisi, G.L. Liguori, D. D'Andrea, and M.G. Persico Role of the EGF-CFC gene cripto in cell differentiation and embryo development Gene 287 2002 33 37
93. M. Modo, P. Rezaie, P. Heuschling, S. Patel, D.K. Male, and H. Hodges Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response Brain Res. 958 2002 70 82
94. A. Morizane, J. Takahashi, Y. Takagi, Y. Sasai, and N. Hashimoto Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through stromal cell-derived inducing activity J. Neurosci. Res. 69 2002 934 939
95. K.A. Moses, F. DeMayo, R.M. Braun, J.L. Reecy, and R.J. Schwartz Embryonic expression of an Nkx2-5/Cre gene using ROSA26 reporter mice Genesis 31 2001 176 180
96. I. Munoz-Sanjuan, and A.H. Brivanlou Neural induction, the default model and embryonic stem cells Nat. Rev., Neurosci. 3 2002 271 280
97. S. Okabe, K. Forsberg-Nilsson, A.C. Spiro, M. Segal, and R.D. McKay Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro Mech. Dev. 59 1996 89 102
98. C.W. Olanow, T. Freeman, and J. Kordower Transplantation of embryonic dopamine neurons for severe Parkinson's disease N. Engl. J. Med. 345 2001 146 (author reply 147)
99. D.D. O'Leary, and D.G. Wilkinson Eph receptors and ephrins in neural development Curr. Opin. Neurobiol. 9 1999 65 73
100. S. Ooto, M. Haruta, Y. Honda, H. Kawasaki, Y. Sasai, and M. Takahashi Induction of the differentiation of lentoids from primate embryonic stem cells Invest. Ophthalmol. Visual Sci. 44 2003 2689 2693
101. T. Ostenfeld, Y.T. Tai, P. Martin, N. Deglon, P. Aebischer, and C.N. Svendsen Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons J. Neurosci. Res. 69 2002 955 965
102. B. Pakkenberg, A. Moller, H.J. Gundersen, A. Mouritzen Dam, and H. Pakkenberg The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method J. Neurol. Neurosurg. Psychiatry 54 1991 30 33
103. S. Palfi, L. Leventhal, Y. Chu, S.Y. Ma, M. Emborg, R. Bakay, N. Deglon, P. Hantraye, P. Aebischer, and J.H. Kordower Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration J. Neurosci. 22 2002 4942 4954
104. S. Park, K.S. Lee, Y.J. Lee, H.A. Shin, H.Y. Cho, K.C. Wang, Y.S. Kim, H.T. Lee, K.S. Chung, E.Y. Kim, and J. Lim Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors Neurosci. Lett. 359 2004 99 103
105. A. Perrier, T. Viviane, T. Barberi, M. Rubio, J. Bruses, N. Topf, N. Harrison, and L. Studer Derivation of midbrain dopaminergic neurons from human embryonic stem cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 12543 12548
106. M.G. Persico, G.L. Liguori, S. Parisi, D. D'Andrea, D.S. Salomon, and G. Minchiotti Cripto in tumors and embryo development Biochim. Biophys. Acta 1552 2001 87 93
107. B. Picconi, D. Centonze, K. Hakansson, G. Bernardi, P. Greengard, G. Fisone, M.A. Cenci, and P. Calabresi Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia Nat. Neurosci. 6 2003 501 506
108. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. DiIorio, L.I. Golbe, and R.L. Nussbaum Mutation in the α-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
109. R. Possemato, K. Eggan, B.J. Moeller, R. Jaenisch, and L. Jackson-Grusby Flp recombinase regulated lacZ expression at the ROSA26 locus Genesis 32 2002 184 186
110. X. Qi, T.G. Li, J. Hao, J. Hu, J. Wang, H. Simmons, S. Miura, Y. Mishina, and G.Q. Zhao BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways Proc. Natl. Acad. Sci. U. S. A. 101 2004 6027 6032
111. J.L. Ridet, N. Deglon, and P. Aebischer Gene transfer techniques for the delivery of GDNF in Parkinson's disease Novartis Found. Symp. 231 2000 202 215 (discussion 215-9, 302-6)
112. J. Rodriguez-Pallares, M.J. Guerra, and J.L. Labandeira-Garcia Elimination of serotonergic cells induces a marked increase in generation of dopaminergic neurons from mesencephalic precursors Eur. J. Neurosci. 18 2003 2166 2174
113. N.S. Roy, T. Nakano, H.M. Keyoung, M. Windrem, W.K. Rashbaum, M.L. Alonso, J. Kang, W. Peng, M.K. Carpenter, J. Lin, M. Nedergaard, and S.A. Goldman Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord Nat. Biotechnol. 22 2004 297 305
114. P. Sacchetti, L.A. Brownschidle, J.G. Granneman, and M.J. Bannon Characterization of the 5'-flanking region of the human dopamine transporter gene Brain Res. Mol. Brain Res. 74 1999 167 174
115. K. Sakurada, M. Ohshima-Sakurada, TD. Palmer, and FH. Gage Nurr1, and orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain Development 126 1999 4017 4026
116. Y. Sasai, and E.M. De Robertis Ectodermal patterning in vertebrate embryos Dev. Biol. 182 1997 5 20
117. O. Saucedo-Cardenas, J.D. Quintana-Hau, W.D. Le, M.P. Smidt, J.J. Cox, F. De Mayo, J.P. Burbach, and O.M. Conneely Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons Proc. Natl. Acad. Sci. U. S. A. 95 1998 4013 4018
118. A.H. Schapira Neuroprotection in PD-a role for dopamine agonists? Neurology 61 2003 S34 S42
119. J. Schumacher, S. Ellias, E. Palmer, H. Kott, J. Dinsmore, P. Dempsey, A. Fischman, C. Thomas, R. Feldman, S. Kassissieh, R. Rainen, C. Manhart, J. Fink, and O. Isacson Transplantation of embryonic porcine mesencephalic tissue in patients with Parkinson's disease Neurology 54 2000 1042 1050
120. E.V. Semina, R.E. Ferrell, H.A. Mintz-Hittner, P. Bitoun, W.L. Alward, R.S. Reiter, C. Funkhauser, S. Daack-Hirsch, and J.C. Murray A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD Nat. Genet. 19 1998 167 170
121. E.V. Semina, J.C. Murray, R. Reiter, R.F. Hrstka, and J. Graw Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice Hum. Mol. Genet. 9 2000 1575 1585
122. Y. Shi, D. Chichung Lie, P. Taupin, K. Nakashima, J. Ray, R.T. Yu, F.H. Gage, and R.M. Evans Expression and function of orphan nuclear receptor TLX in adult neural stem cells Nature 427 2004 78 83
123. L.S. Shihabuddin, J.A. Hertz, V.R. Holets, and S.R. Whittemore The adult CNS retains the potential to direct region-specific differentiation of a transplanted neuronal precursor cell line J. Neurosci. 15 1995 6666 6678
124. J.W. Shim, H.C. Koh, M.Y. Chang, E. Roh, C.Y. Choi, Y.J. Oh, H. Son, Y.S. Lee, L. Studer, and S.H. Lee Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL J. Neurosci. 24 2004 843 852
125. K. Shimozaki, K. Nakashima, H. Niwa, and T. Taga Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis- inducing cultures Development 130 2003 2505 2512
126. M.F. Siddiqui, S. Rast, M.J. Lynn, A.P. Auchus, and R.F. Pfeiffer Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey Parkinsonism Relat. Disord. 8 2002 277 284
127. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nussbaum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, M.R. Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy, and K. Gwinn-Hardy Alpha-synuclein locus triplication causes Parkinson's disease Science 302 2003 841
128. C. Sirard, J.L. de la Pompa, A. Elia, A. Itie, C. Mirtsos, A. Cheung, S. Hahn, A. Wakeham, L. Schwartz, S.E. Kern, J. Rossant, and T.W. Mak The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo Genes Dev. 12 1998 107 119
129. M.P. Smidt, H.S. van Schaick, C. Lanctot, J.J. Tremblay, J.J. Cox, A.A. van der Kleij, G. Wolterink, J. Drouin, and J.P. Burbach A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons Proc. Natl. Acad. Sci. U. S. A. 94 1997 13305 13310
130. M.P. Smidt, C.H. Asbreuk, J.J. Cox, H. Chen, R.L. Johnson, and J.P. Burbach A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b Nat. Neurosci. 3 2000 337 341
131. E.Y. Snyder, G.Q. Daley, and M. Goodell Taking stock and planning for the next decade: realistic prospects for stem cell therapies for the nervous system J. Neurosci. Res. 76 2004 157 168
132. -/- embryonic stem cells Mol. Cell. Neurosci. 2004 (in press)
133. K.C. Sonntag, R. Simantov, K.S. Kim, and O. Isacson Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation Eur. J. Neurosci. 19 2004 1141 1152
134. P. Soriano Generalized lacZ expression with the ROSA26 Cre reporter strain [letter] Nat. Genet. 21 1999 70 71
135. C.E. Sortwell Strategies for the augmentation of grafted dopamine neuron survival Front. Biosci. 8 2003 s522 s532
136. C.E. Sortwell, M.R. Pitzer, and T.J. Collier Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival Exp. Neurol. 165 2000 268 277
137. C.E. Sortwell, M.D. Camargo, M.R. Pitzer, S. Gyawali, and T.J. Collier Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval Exp. Neurol. 169 2001 23 29
138. J.W. Streilein Unraveling immune privilege Science 270 1995 1158 1159
139. S. Sumitran, P. Anderson, H. Widner, and J. Holgersson Porcine embryonic brain cell cytotoxicity mediated by human natural killer cells Cell Transplant 8 1999 601 610
140. Z.H. Sun, Y.L. Lai, W.W. Zeng, D. Zhao, H.C. Zuo, and Z.P. Xie Neural stem/progenitor cells survive and differentiate better in PD rats than in normal rats Acta Neurochir., Suppl. 87 2003 169 174
141. L. Sun, J. Lee, and H.A. Fine Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury J. Clin. Invest. 113 2004 1364 1374
142. A.R. Tambur Transplantation immunology and the central nervous system Neurol. Res. 26 2004 243 255
143. V. Tropepe, S. Hitoshi, C. Sirard, T.W. Mak, J. Rossant, and D. van der Kooy Direct neural fate specification from embryonic stem cells. A primitive mammalian neural stem cell stage acquired through a default mechanism Neuron 30 2001 65 78
144. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, S. Gispert, Z. Ali, D. Del Turco, A.R. Bentivoglio, D.G. Healy, A. Albanese, R. Nussbaum, R. Gonzalez-Maldonado, T. Deller, S. Salvi, P. Cortelli, W.P. Gilks, D.S. Latchman, R.J. Harvey, B. Dallapiccola, G. Auburger, and N.W. Wood Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
145. M. Vila, V. Jackson-Lewis, S. Vukosavic, R. Djaldetti, G. Liberatore, D. Offen, S.J. Korsmeyer, and S. Przedborski Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 98 2001 2837 2842
146. C.M. Ward, and P.L. Stern The human cytomegalovirus immediate-early promoter is transcriptionally active in undifferentiated mouse embryonic stem cells Stem Cells 20 2002 472 475
147. H. Widner Immunologic aspects of intracerebral CNS tissue transplantation O. Lindvall Basic and Clinical Aspects of Neuroscience vol. 5 1993 Springer-Verlag Heidelberg 63 74
148. S.I. Wilson, and T. Edlund Neural induction: toward a unifying mechanism Nat. Neurosci. 4 2001 1161 1168 (Suppl.)
149. P. Wu, Y.I. Tarasenko, Y. Gu, L.Y. Huang, R.E. Coggeshall, and Y. Yu Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat Nat. Neurosci. 5 2002 1271 1278
150. A. Wutz, and R. Jaenisch A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation Mol. Cell 5 2000 695 705
151. M. Yang, A.E. Donaldson, Y. Jiang, and L. Iacovitti Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells Cell. Mol. Neurobiol. 23 2003 851 864
152. W. Ye, K. Shimamura, J.L. Rubenstein, M.A. Hynes, and A. Rosenthal FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate Cell 93 1998 755 766
153. Q.L. Ying, M. Stavridis, D. Griffiths, M. Li, and A. Smith Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture Nat. Biotechnol. 21 2003 183 186
154. T. Yoshizaki, M. Inaji, H. Kouike, T. Shimazaki, K. Sawamoto, K. Ando, I. Date, K. Kobayashi, T. Suhara, Y. Uchiyama, and H. Okano Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells Neurosci. Lett. 363 2004 33 37
155. Y. Yue, D.A. Widmer, A.K. Halladay, D.P. Cerretti, G.C. Wagner, J.L. Dreyer, and R. Zhou Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2 J. Neurosci. 19 1999 2090 2101
156. B.P. Zambrowicz, A. Imamoto, S. Fiering, L.A. Herzenberg, W.G. Kerr, and P. Soriano Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells Proc. Natl. Acad. Sci. U. S. A. 94 1997 3789 3794
157. W.M. Zawada, M.K. Meintzer, P. Rao, J. Marotti, X. Wang, J.E. Esplen, E.D. Clarkson, C.R. Freed, and K.A. Heidenreich Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons Brain Res. 891 2001 185 196
158. X. Zeng, J. Chen, J.F. Sanchez, M. Coggiano, O. Dillon-Carter, J. Petersen, and W.J. Freed Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation Stem Cells 21 2003 647 653
159. S. Zhang, M. Wernig, I.D. Duncan, O. Brüstle, and J.A. Thomson In vitro differentiation of transplantable neural precursors from human embryonic stem cells Nat. Biotechnol. 19 2001 1129 1133
160. R. Zhang, Z. Zhang, C. Zhang, L. Zhang, A. Robin, Y. Wang, M. Lu, and M. Chopp Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat J. Neurosci. 24 2004 5810 5815
161. M. Zhao, S. Momma, K. Delfani, M. Carlen, R.M. Cassidy, C.B. Johansson, H. Brismar, O. Shupliakov, J. Frisen, and A.M. Janson Evidence for neurogenesis in the adult mammalian substantia nigra Proc. Natl. Acad. Sci. U. S. A. 100 2003 7925 7930
162. S. Zhao, S. Maxwell, A. Jimenez-Beristain, J. Vives, E. Kuehner, J. Zhao, C. O'Brien, C. de Felipe, E. Semina, and M. Li Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons Eur. J. Neurosci. 19 2004 1133 1140
163. B. Zhu, L. Luo, Y. Chen, D.W. Paty, and M.S. Cynader Intrathecal Fas ligand infusion strengthens immunoprivilege of central nervous system and suppresses experimental autoimmune encephalomyelitis J. Immunol. 169 2002 1561 1569
164. T.P. Zwaka, and J.A. Thomson Homologous recombination in human embryonic stem cells Nat. Biotechnol. 21 2003 319 321